New rapid test could save lives of febrile children in africa

NCT ID NCT06422338

Recruiting now Diagnosis Sponsor: Barcelona Institute for Global Health Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 29, 2026 · Updated 2 times

Summary

This study tests whether a rapid triage test (suPAR) can help doctors make better decisions about admitting or discharging children with fever. Over 5,000 children aged 2 months to 5 years in sub-Saharan Africa will be randomly assigned to standard care or standard care plus the test. The goal is to see if the test reduces inappropriate discharges and improves health outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: suPAR point-of-care test
What this could lead to: If successful, this test could help doctors quickly identify which febrile children need hospital care, potentially saving lives and reducing unnecessary admissions.
What could go wrong: This is a large trial, but the test is new and may not improve outcomes over standard care. It is also limited to children in sub-Saharan Africa, so results may not apply elsewhere.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHILD, ONLY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

CHILD syndrome infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHILD, ONLY FEBRILE ILLNESS INFECTIOUS DISEASE

Contacts and locations

Locations

CERMEL Centre de Recherches Médicales de Lambaréné
RECRUITING

Lambaréné, Moyen-Ogooué Province, 242, Gabon
Mopeia Sede Health Centre
RECRUITING

Mopeia, Mozambique

More trials for these conditions

Other studies related to the condition(s) this trial covers.